No worries Cancun, yes Blackeyes for sure today. Anxiously awaiting FLD. I truly believe there is more to learn about BoM, a LOT more for ALL of cardio, kidney, cognitive ... and not 100% entirely convinced yet, that we aren't still on a possible path to approval WITHOUT another P3 for cardio. Not saying I am "confident" about that, at all, though.

I do have a feeling, a strong feeling actually, that there is a LOT of useful data coming with FLD, and a potential for some delayed gratification. 

My worry has NEVER been about the science, it has ALWAYS been about the study design & endpoints. If BoM comes in with FLD showing 22% overall RRR with marginal time to first occurrence over placebo OVERALL ... BUT ... 35% RRR and exception time to first occurrence delays with CRESTOR? .... THEN, I am going to spontaneously combust. 

I will wait for FLD, i am LONG on RVX ... but I am madder than spermatozoa in a condom about the study design, and % application relative to % market share of Crestor & Lipitor, especially given some of the previously known information.

Gonna be chewing on gravel for the next 6 weeks.